Search results
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 21 hours agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
Zacks via Yahoo Finance· 3 days agoEarlier in the month, BMY announced that a late-stage study seeking to expand the label of Opdivo in...
Immunotherapy for stomach cancer: Types and effectiveness
Medical News Today· 2 days agoImmunotherapy may help shrink a tumor or slow the growth of cancer cells. People may have it in...
Regeneron faces new biosimilar threats; an AI biotech lays off staff
BioPharma Dive via Yahoo Finance· 3 days agoThey’re also starting a preclinical cancer immunotherapy program. OSE will receive €13.5 million...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 2 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 5 days agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...
This Unpopular Dividend Stock Is a Buy
The Motley Fool via AOL· 2 days agoBMS is facing one of the steepest patent cliffs in the industry come 2028 when cancer medication Opdivo and blood thinner Eliquis could both face generic...
FDA sets new review date for Halozyme's drug delivery tech By Investing.com
Investing.com· 4 days agoFood and Drug Administration (FDA) has updated the Prescription Drug User Fee Act (PDUFA) goal date...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks via Yahoo Finance· 21 hours agoIovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its...
Anavex Life Sciences Announces Expansion of Leadership Team
Morningstar· 3 days agoNEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics ...